Universe Pharmaceuticals INC Capital Expenditures
Universe Pharmaceuticals INC (UPC) reported Capital Expenditures of $266.77 million for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-01-29
| Period end | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | $266.77M 20-F · filed 2026-01-29 | ||
| 2024-09-30 | $208.32M 20-F · filed 2026-01-29 | $208.32K 20-F · filed 2025-04-29 | |
| 2024-03-31 | $30.19K 6-K · filed 2024-09-20 | ||
| 2023-09-30 | $44.17M 20-F · filed 2026-01-29 | $44.17K 20-F · filed 2024-01-30 | |
| 2023-03-31 | $646.00 6-K · filed 2024-09-20 | ||
| 2022-09-30 | $93.70K 20-F · filed 2025-04-29 | ||
| 2022-03-31 | $55.63K 6-K · filed 2023-08-31 | ||
| 2021-09-30 | $444.50K 20-F · filed 2024-01-30 | ||
| 2021-03-31 | $50.88K 6-K · filed 2022-08-16 | ||
| 2020-09-30 | $51.80K 20-F · filed 2023-02-10 | ||
| 2019-09-30 | $86.32K 20-F · filed 2022-01-31 |